| Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group … OA Cornely, A Alastruey-Izquierdo, D Arenz, SCA Chen, E Dannaoui, ... The Lancet infectious diseases 19 (12), e405-e421, 2019 | 1479 | 2019 |
| ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013 OA Cornely, S Arikan‐Akdagli, E Dannaoui, AH Groll, K Lagrou, ... Clinical Microbiology and Infection 20, 5-26, 2014 | 734 | 2014 |
| ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others AM Tortorano, M Richardson, E Roilides, A Van Diepeningen, M Caira, ... Clinical Microbiology and Infection 20, 27-46, 2014 | 477 | 2014 |
| ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi A Chowdhary, JF Meis, J Guarro, GS De Hoog, S Kathuria, MC Arendrup, ... Clinical Microbiology and Infection 20, 47-75, 2014 | 321 | 2014 |
| Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species M Lackner, GS de Hoog, PE Verweij, MJ Najafzadeh, I Curfs-Breuker, ... Antimicrobial Agents and Chemotherapy 56 (5), 2635-2642, 2012 | 286 | 2012 |
| Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the … M Hoenigl, J Salmanton-García, TJ Walsh, M Nucci, CF Neoh, JD Jenks, ... The Lancet Infectious Diseases 21 (8), e246-e257, 2021 | 249 | 2021 |
| Scedosporium and Lomentospora: an updated overview of underrated opportunists A Ramirez-Garcia, A Pellon, A Rementeria, I Buldain, E Barreto-Bergter, ... Medical Mycology 56 (suppl_1), S102-S125, 2018 | 227 | 2018 |
| Proposed nomenclature for Pseudallescheria, Scedosporium and related genera M Lackner, GS de Hoog, L Yang, L Ferreira Moreno, SA Ahmed, ... Fungal Diversity 67, 1-10, 2014 | 194 | 2014 |
| Laboratory diagnosis of mucormycosis: current status and future perspectives M Lackner, R Caramalho, C Lass-Flörl Future microbiology 9 (5), 683-695, 2014 | 159 | 2014 |
| Systematic overview of cost–effectiveness thresholds in ten countries across four continents R Schwarzer, U Rochau, K Saverno, B Jahn, B Bornschein, ... Journal of comparative effectiveness research 4 (5), 485-504, 2015 | 143 | 2015 |
| Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope® D Seidel, A Meißner, M Lackner, E Piepenbrock, J Salmanton-García, ... Critical reviews in microbiology 45 (1), 1-21, 2019 | 120 | 2019 |
| DNA barcoding of fungi causing infections in humans and animals L Irinyi, M Lackner, GS De Hoog, W Meyer Fungal biology 120 (2), 125-136, 2016 | 100 | 2016 |
| Analysis of antifungal resistance genes in Candida albicans and Candida glabrata using next generation sequencing K Spettel, W Barousch, A Makristathis, I Zeller, M Nehr, B Selitsch, ... PloS one 14 (1), e0210397, 2019 | 96 | 2019 |
| Recent trends in molecular diagnostics of yeast infections: from PCR to NGS T Gabaldón FEMS Microbiology Reviews 43 (5), 517-547, 2019 | 94 | 2019 |
| Commentaries: name changes in medically important fungi and their implications for clinical practice GS De Hoog, V Chaturvedi, DW Denning, PS Dyer, JC Frisvad, D Geiser, ... Journal of clinical microbiology 53 (4), 1056-1062, 2015 | 91 | 2015 |
| Susceptibility and diversity in the therapy-refractory genus Scedosporium M Lackner, F Hagen, JF Meis, AHG Gerrits van den Ende, D Vu, V Robert, ... Antimicrobial agents and chemotherapy 58 (10), 5877-5885, 2014 | 84 | 2014 |
| Positions and Numbers of FKS Mutations in Candida albicans Selectively Influence In Vitro and In Vivo Susceptibilities to Echinocandin Treatment M Lackner, M Tscherner, M Schaller, K Kuchler, C Mair, B Sartori, F Istel, ... Antimicrobial agents and chemotherapy 58 (7), 3626-3635, 2014 | 84 | 2014 |
| Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients S Eigl, J Prattes, M Lackner, B Willinger, B Spiess, M Reinwald, B Selitsch, ... Critical care 19, 1-10, 2015 | 83 | 2015 |
| Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon? T Zoran, B Sartori, L Sappl, M Aigner, F Sánchez-Reus, A Rezusta, ... Frontiers in Microbiology 9, 516, 2018 | 82 | 2018 |
| Clinical evaluation of a Mucorales-specific real-time PCR assay in tissue and serum samples J Springer, M Lackner, C Ensinger, B Risslegger, CO Morton, D Nachbaur, ... Journal of medical microbiology 65 (12), 1414-1421, 2016 | 81 | 2016 |
Jacques F. Meis, MDUniversity of Cologne在 uk-koeln.de 的电子邮件经过验证
